Диссертация (1146664), страница 20
Текст из файла (страница 20)
Cardiovascular risk in diabetic women // Curr.Atheroscler. ReP. – 2003. – Vol. 5. – P. 79–81.100. Bots M. L., Hoes A. W., Koudstaal P. J. et al. Common carotid intima–mediathickness and risk of stroke and myocardial infarction. The Rotterdam Study //Circulation. – 1997. – Vol. 96. – P. 1432–1437.101. Bouloumie A., Marumo T., Lafontan M., et al.
Leptin induces oxidative stressin human endothelial cells // FASEB J. – 1999. – Vol. 13. – P. 1231–1238.102. Bouzegrhane F., Gaetan T. Is angiotensin II a proliferative factor of cardiacfibroblasts? // Cardiovascular Research. – 2002. – Vol. 53. - P. 304–312.103. Bozaoglu K., Bolton K., McMillan J. et al. Chemerin is a novel adipokineassociated with obesity and metabolic syndrome // Endocrinology. – 2007. –Vol. 148.
– P. 4687–4694.104. Bozaoglu K., Curran J. E., Stocker C. J. et al. Chemerin, a novel adipokine inthe regulation of angiogenesis // J. Clin. Endocrinol. Metab. – 2010. – Vol. 95.– P. 2476–2485.126105. Brochu M., Starling R. D., Tohernof A. et al. Visceral adipose tissue is anindependent correlate of glucose disposal in older obese postmenopausalwomen // J. Clin. Endocrinol. Metab.
– 2000. – Vol. 85. – P. 2378–2384.106. Calabro P., Samudio I., Willerson J. T., Yeh E. T. Resistin promotes smoothmuscle cell proliferation through activation of extracellular signal-regulatedkinase 1/2 and phosphatidylinositol 3-kinase pathways // Circulation. – 2004. –Vol. 110. – P. 3335–3340.107. Camejo G. Lysophospholipids: Effectors mediating the contribution ofdyslipidemia to calcification associated with atherosclerosis // Atherosclerosis.– 2010. – Vol. 211. – P.
36–37.108. Capellino S. Montagna P. Villaggio B. et al. Role of estrogens ininflammatory response: expression of estrogen receptors in peritoneal fluidmacrophages from endometriosis // Ann. N. Y. Acad. Sci. – 2006. – Vol. 1069.- P. 263–267.109. Caulin-Glaser T. Primary Prevention of Hypertension in Women // J. Clin.Hypertens. – 2000. – Vol. 2(3). – P.
204–214.110. Cavigiolio G., Jayaraman S. Proteolysis of Apolipoprotein A-I by SecretoryPhospholipase A2. A new Link between inflammation and atherosclerosis // J.Biol. Chem. – 2014. – Feb 12. [Epub ahead of print].111. Chan J. L., Bullen J., Stoyneva V., et al. Recombinant methionyl humanleptin administration to achieve high physiologic or pharmacologic leptinlevels does not alter circulating inflammatory marker levels in humans withleptin sufficiency or excess // J. Clin. Endocrinol. Metab. – 2005. – Vol. 90. –P.
1618–1624.112. Chang Y., Ryu S., Sung E. et al. Nonalkoholic fatty liver disease predictschronic kidney disease in nonhypertensive and nondiabetic korean men //Metabolism. – 2008. – Vol. 57(4). – P. 569–576.113. Gharipour M., Ramezani M. A., Sadeghi M. et al. Sex based levels of Creactive protein and white blood cell count in subjects with metabolic127syndrome: Isfahan Healthy Heart Program // J. Res. Med. Sci. - 2013. –Vol. 18 (6). – P. 467-472.114.
Clausen P, Jensen J. S., Jensen G. et al. Elevated urinary albumin excretion isassociated with impaired arterial dilatory capacity in clinically healthy subjects// Circulation. – 2001. – Vol. 103 (14). – P. 1869-1874.115. Cohn J. N., Johnson G. R., Shabetai R., et al. Ejection fraction, peak exerciseoxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasmanorepinephrine as determinants of prognosis in heart failure // Circulation. –1995. – Vol. 91 (10). – P. 2619–2626.116. Collins P., Rosano G., Casey C.
et al. Ведение женщин с сердечнососудистымрискомвперименопаузе:консенсусевропейскихкардиологов и гинекологов // Climacteric. – 2007. – № 10. – С. 508–526.117. Cooper M. S., Stewart P. M.11B-hydroxysteroid dehydrogenase type 1 and itsrole in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, andinflammation // J. Clin. Endocrinol. Metab. – 2009. – Vol.
94 (12). – P. 4645–4654.118. Coppari R., Ichinose M., Lee C. E. et al. The hypothalamic arcuate nucleus: akey site for mediating leptin’s effects on glucose homeostasis and locomotoractivity // Cell Metabolism. – 2005. – Vol. 1. – P. 63–72.119. Corcoran M. P., Meydani M., Lichtenstein A. H. et al. – Sex hormonemodulation of proinflammatory cytokine and C-reactive protein expression inmacrophages from older men and postmenopausal women // J. Endocrinol. –2010. – Vol. 206 – P. 217–224.120. Correia M. L.
G., Haynes W. G., Rahmouni K., et al. The concept of selectiveleptin resistance: evidence from Agouti yellow obese mice // PathophysiologyDiabetes. – 2002. – Vol. 51 (2). – P.439–442.121. Cuspidi C., Giudici V., Negri F. et al. Left ventricular geometry, ambulatoryblood pressure and extra-cardiacorgan damage in untreated essentialhypertension // Blood Press Monit.
– 2010. –Vol.15 (3). – P. 124–131.128122. Cuspidi C., Meani S.,Valerio C. et al. Metabolic syndrome score andambulatory blood pressure in untreated essential hypertension // BloodPressure Monitoring. – 2005. – Vol. 10 (4). – P. 175–180.123. Dahl T. B., Yndestad A., Skjelland M. et al. Increased expression of visfatinin macrophages of human unstable carotid and coronary atherosclerosis:possible role in inflammation and plaque destabilization // Circulation. – 2007.– Vol. 115. – P. 972–980.124. Davi G., Guagnano M. T., Ciabattoni G., et al. Platelet activation in obesewomen: role of inflammation and oxidant stress // JAMA. – 2002.
– Vol. 288.– P. 2008–2014.125. De Ciuceis C., Rossini C., La Boria E., et al. Immune Mechanisms inHypertension // High Blood Press. Cardiovasc. Prev. – 2014. – Jan 21. [Epubahead of print].126. De Souza Batista C. M., Yang R. Z., Lee M. J. et al. Omentin plasma levelsand gene expression are decreased in obesity // Diabetes. – 2007. – Vol. 56. –P. 1655–1661.127.
Deakin S. P., James R. W. Genetic and environmental factors modulatingserum concentrations and activities of the antioxidant enzyme paraoxonase-1 //Clin. Sci. – 2004. – Vol. 107. – P. 435–447.128. Deedwania P. C. Diabetes and vascular disease: common links in theemerging epidemic of coronary artery disease // Am. J. Cardiol. – 2003. –Vol. 91 (1). – P.
68–71.129. Diamanti-Kandaraskis E. Spina G., Kouli C., Migdalis I. Increasedendothelin-1 levels in women with polycystic ovary syndrome and thebeneficial effect of metformin therapy // J. Clin. Endocrinol. Metab. – 2001. –Vol. 86 (10). – P. 4666–4673.130. Diercks G. F., Stroes E. S., van Boven A.
J. et al. Urinary albumin excretionis related to cardiovascular risk indicators, not to flow-mediated vasodilation.In apparently healthy subjects // Atherosclerosis. – 2002. – Vol. 163 (1). –P. 121–126.129131. Dijk J. M., van der Graat G., Bots M. L. et al. Carotid intima–media thicknessand the risk of new vascular events in patients with manifest atheroscleroticdisease: the SMART study // Eur. Heart J.
– 2006. – Vol. 24. – P. 1971–1978.132. Doria A., Fioretto P., Avogaro A. et al. Insulin resistance associated withsodium-lithium countertransport in essential hypertension // Am. J. Physiol. –1991. – Vol. 261. – P. 684–691.133. Du L. J., Zhou J. G., Ren X. J.
et al. Oxidative mechanism of uric acidinduced CRP expression in human umbilical vein endothelial cellsSichuan //Da Xue Xue Bao Yi Xue Ban. – 2013. – Vol. 44(5). – P. 717–721, 726.134. Edwards C. Sixty years hench-corticosteroids and chronic inflammatorydisease // J. Clin. Endocrinol. Metab. – 2012. – Vol. 97 (5). – P. 1443–1451.135.
Eguchi K. Ambulatory blood pressure monitoring in diabetes and obesity //Int. J. Hypertens. – 2011:954757.136. Eikelis N., Lambert G., Wiesner G. et al. Extraadipocyte leptin release inhuman obesity and its relation to sympathoadrenal function // Am. J.
Physiol.Endocrinol. Metab. – 2004. – Vol. 286. – P. 744–752.137. El Azeem H. A., Khalek el-S. A., El-Akabawy H. et al. Association betweennonalcoholic fatty liver disease and the incidence of cardiovascular and renalevents // J. Saudi Heart Assoc. – 2013. – Vol. 25 (4). – P. 239–246.138. Eleftheriadis T., Pissas G., Karioti A. et al.
Uric acid induces caspase-1activation, IL-1β secretion and P2X7 receptor dependent proliferation inprimary human lymphocytes // Hippokratia. – 2013. – Vol. 17 (2). – P. 141–145.139. Elseweidy M. M., Elswefy S. E., Younis N. N. et al. Pyridoxamine, aninhibitor of protein glycation, in relation to microalbuminuria andproinflammatory cytokines in experimental diabetic nephropathy // Exp. Biol.Med. (Maywood). – 2013. – Vol. 238 (8). – P.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
